Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
Xencor, Inc.
Xencor, Inc.
AstraZeneca
Atavistik Bio, Inc
Compass Therapeutics
PMV Pharmaceuticals, Inc
Alterome Therapeutics, Inc.
Eli Lilly and Company
BeOne Medicines
Bayer
Psyence Australia Pty Ltd
Genmab
Jazz Pharmaceuticals
AstraZeneca
AstraZeneca
Myeloid Therapeutics
Tizona Therapeutics, Inc
BioNTech SE
IDEAYA Biosciences
MacroGenics
Daiichi Sankyo
Adela, Inc
Doma Biopharmaceutical(Suzhou)Co., Ltd.
Second Life Therapeutics
Elephas
Elephas
GlaxoSmithKline
Sairopa B.V.
Tanabe Pharma America, Inc.
NeoTX Therapeutics Ltd.
Tempus AI
Incyte Corporation
Tempest Therapeutics
Pfizer
Guardant Health, Inc.
Exelixis
Incyte Corporation
Merck Sharp & Dohme LLC
858 Therapeutics, Inc.
Totus Medicines
Marengo Therapeutics, Inc.
NextPoint Therapeutics, Inc.
ModeX Therapeutics, An OPKO Health Company
Klus Pharma Inc.
Novartis
Tempus AI
Theratechnologies
Singlera Genomics Inc.
Seagen Inc.
Xencor, Inc.
Agenus Inc.